Skip to main content
Figure 3 | Virology Journal

Figure 3

From: Inhibition of mTORC1 inhibits lytic replication of Epstein-Barr virus in a cell-type specific manner

Figure 3

Higher doses of rapamycin are not effective in inhibiting EBV lytic replication in AGS-BDneo cells. A, AGS-BDneo cells, B, Raji cells. Cells were treated with rapamycin as indicated for 24 hr prior to the induction of lytic replication. Western blot analysis was performed with anti-BMRF1 and anti-tubulin antibodies. The BMRF1 levels were quantified and standardized to tubulin levels. The resulting BMRF1 protein levels are presented, relative to induced cells (with no rapamycin treatment).

Back to article page